Kyriakos Dimitriadis, Nikolaos Pyrpyris, Aggelos Papanikolaou, Eirini Beneki, Panagiotis Tsioufis, Alexios Antonopoulos, Christos Fragoulis, Fotis Tatakis, Georgios Koutsopoulos, Konstantinos Aznaouridis, Konstantina Aggeli, Konstantinos Tsioufis
Ultra-low contrast percutaneous coronary interventions (ULPCIs) are a novel field of interventional cardiology, aiming to reduce the risk of contrast-induced nephropathy (CIN), which is a well-described adverse event after angiography. CIN is a well-described adverse event following PCI, especially in high-risk patients, i.e., patients with an already deteriorating renal function or chronic kidney disease, as well as patients of advanced age or requiring an increased amount of contrast during their intervention...
December 4, 2023: Journal of Clinical Medicine